Concepedia

Yingxiao Cao

YC

Statistics

Publications

5

Citations

112

H-Index

5

Active since

2020

Affiliations

Xingtai People's Hospital(Current)

Hebei Medical University

Shenyang First People's Hospital

Yingxiao Cao is an author at Xingtai People's Hospital specializing in oncology, pharmacology, and medicine.

ORCID

Publications per year

2020–2020

5

Publications

5

<i>Retracted:</i> CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells

Yingxiao Cao, Xin Li, Shiqi Kong et al. · Journal of Cellular and Molecular Medicine · 2020 · 37 citations · Full text

, , +13

miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7

Shiqi Kong, Yanwei Fang, Bingqian Wang et al. · Journal of Cellular and Molecular Medicine · 2020 · 23 citations · Full text

, , +17

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway

Shiqi Kong, Yingxiao Cao, Xin Li et al. · Journal of Cellular and Molecular Medicine · 2020 · 23 citations · Full text

, , +17

miR‐1254 inhibits progression of glioma in vivo and in vitro by targeting CSF‐1

Xin Li, Shiqi Kong, Yingxiao Cao · Journal of Cellular and Molecular Medicine · 2020 · 19 citations · Full text

, , +17

<i>Retracted:</i> Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction

Yingxiao Cao, Shiqi Kong, Yu‐ling Xin et al. · Journal of Cellular and Molecular Medicine · 2020 · 10 citations · Full text

, , +17

1–5 of 5